Entasis Therapeutics Holdings  logo
Entasis Therapeutics Holdings ETTX

Quarterly report 2022-Q1
added 12-23-2023

report update icon

Entasis Therapeutics Holdings Financial Ratios 2011-2026 | ETTX

Annual Financial Ratios Entasis Therapeutics Holdings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.6 -1.3 -1.6 -0.6 - - - - - - -

P/S

- - 9.9 4.0 - - - - - - -

EPS

-1.1 -2.1 -3.3 -12.3 -13795.8 - - - - - -

EV (Enterprise Value)

51.1 M 20 M 62.2 M -23.1 M 59.5 M 53.4 M - - - - -

EBITDA per Share

-1.2 -2.25 -3.56 -11.1 - - - - - - -

EV/EBITDA

-0.4 -0.8 -1.1 1.0 - - - - - - -

PEG

- 0.12 -0.02 0.01 - - - - - - -

P/B

2.4 1.2 1.6 0.2 - - - - - - -

P/CF

-1.7 -1.4 -1.6 -0.6 - - - - - - -

ROE %

-151.03 -96.57 -104.02 -39.76 - - - - - - -

ROA %

-115.20 -82.03 -85.92 -36.91 - - - - - - -

ROCE %

-167.62 -102.34 -107.95 -46.00 - - - - - - -

Current Ratio

4.2 6.6 5.7 14.0 - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Entasis Therapeutics Holdings

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - -0.32 - -0.26 -0.29 -0.29 - -0.37 -0.78 -1.15 - -0.27 -1.02 -0.99 - -20.33 -453.6 -844.01 - -5106.75 - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

- - - -0.33 - -0.29 -0.32 -0.34 - -0.35 -0.78 -1.16 - -0.31 -1.07 -1.08 - -11.6 -549 -927 - -5.13 K - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

-183.36 -213.41 -151.78 -174.45 -76.90 -94.79 -82.63 -87.14 -100.17 -106.52 -94.98 -90.94 -60.18 -70.40 -74.28 -58.06 -30.01 -15.09 10.05 16.97 14.92 14.92 - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

-69.23 -93.64 -83.43 -102.36 -63.59 -79.50 -71.01 -75.81 -83.68 -90.51 -81.43 -83.92 -58.41 -67.90 -70.56 -50.76 -27.86 -42.02 -46.69 -40.26 -14.16 -14.16 - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

-191.36 -224.35 -161.65 -186.71 -86.69 -106.94 -94.20 -96.49 -103.19 -110.71 -97.98 -95.01 -65.55 -77.81 -82.56 -66.66 -34.94 -19.68 7.84 16.32 15.26 15.26 - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

- - - 1.6 4.2 5.3 6.0 6.2 6.6 9.1 7.9 5.0 5.8 5.8 5.8 5.8 14.0 14.0 14.0 14.0 6.0 6.0 - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Entasis Therapeutics Holdings , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Biotechnology industry

Issuer Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
- - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.89 - $ 6.54 M chinaChina
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
$ 22.35 0.68 % $ 3.7 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - russiaRussia
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K usaUSA
BioNTech SE BioNTech SE
BNTX
$ 103.69 2.08 % $ 27.2 B germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
$ 1.48 -0.67 % $ 235 M franceFrance
Akouos Akouos
AKUS
- 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
- - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 3.65 22.48 % $ 6.01 M israelIsrael
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M germanyGermany
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M canadaCanada
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 4.08 0.74 % $ 436 M usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
- 17.91 % $ 11.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 22.65 1.25 % $ 2.88 B usaUSA
Edesa Biotech Edesa Biotech
EDSA
$ 16.23 2.08 % $ 51.9 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M usaUSA
Athira Pharma Athira Pharma
ATHA
- - $ 269 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.42 0.71 % $ 378 M britainBritain
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B britainBritain
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.79 4.79 % $ 27.9 M israelIsrael
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M usaUSA
Exelixis Exelixis
EXEL
$ 45.0 0.69 % $ 12.2 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B cayman-islandsCayman-islands
Завод ДИОД Завод ДИОД
DIOD
- - - russiaRussia